FTI Consulting: Earnings Need To Catch Up With Revenue

FTI Consulting is rated Buy with a $176 price target, implying 33% upside, as the current valuation is viewed as already discounting expected 2026 weakness. Revenue growth and pricing remain strong, but rising central expenses and lower employee utilization are pressuring profitability. Achieving 2026 EPS guidance depends on cutting SG&A by $12 million and improving billable-hour utilization in the second half.

Analysis

FCN’s key debate is no longer demand or billing rate resilience; it is whether the firm can restore operating leverage without impairing the senior talent base that drives its premium pricing. A $12 million SG&A reduction is modest in absolute terms, but utilization recovery is inherently more consequential: incremental billable hours carry high contribution margins, so a sustained utilization inflection could produce earnings upside disproportionate to revenue growth over the next 2-3 quarters. Conversely, persistent underutilization risks a negative loop in which compensation costs remain sticky while revenue-producing professionals become more vulnerable to attrition.

The market is likely assigning a low probability to a clean second-half execution recovery, creating asymmetry if management demonstrates sequential margin improvement before 2026 estimates are reset. Near-term catalysts are quarterly utilization, headcount growth versus revenue growth, and SG&A as a percentage of revenue; evidence of either cost discipline or improving staffing absorption should support multiple expansion within 1-3 months. The falsifier is another quarter of declining utilization combined with elevated central costs, which would turn the earnings issue from a timing mismatch into a structural margin-reset narrative and likely force further estimate cuts.

A contrarian consideration is that advisory peers exposed to restructuring, litigation, and regulatory complexity can see countercyclical demand when macro conditions weaken, partially insulating FCN’s top line. That does not solve the cost issue, but it means a broad economic slowdown could be less damaging to FCN than to cyclical consulting peers if engagement mix shifts toward higher-value restructuring and investigations work. The appropriate trade is therefore an execution-driven long rather than a broad consulting-sector beta position.

Key Decisions for Investors

• Initiate a starter long FCN only after the next earnings release confirms sequential utilization improvement and SG&A leverage; target a 6-12 month holding period. Upside is a rerating as 2026 EPS risk is removed, while failure to show both metrics warrants exiting rather than averaging down.
• Use a 3-6 month defined-risk call structure on FCN around the next reporting catalyst only if implied volatility is not elevated versus its post-earnings range. The thesis requires a visible margin inflection, making outright short-dated calls unattractive ahead of unverified execution.
• Monitor revenue per billable employee, utilization, voluntary attrition, and central-cost growth each quarter. Treat any combination of declining utilization and rising compensation/SG&A as a thesis break, even if reported revenue continues to grow.
• For a relative-value expression, consider long FCN versus a short basket of more economically sensitive consulting exposure only after FCN’s operating metrics stabilize; the hedge is intended to isolate potential restructuring/investigations demand resilience, not to offset company-specific execution risk.